Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Biocryst Pharma Inc (BCRX)

Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,052,288
  • Shares Outstanding, K 206,331
  • Annual Sales, $ 331,410 K
  • Annual Income, $ -226,540 K
  • 60-Month Beta 1.96
  • Price/Sales 3.27
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade BCRX with:

Options Overview Details

View History
  • Implied Volatility 56.52% ( -0.89%)
  • Historical Volatility 72.22%
  • IV Percentile 31%
  • IV Rank 15.97%
  • IV High 132.06% on 02/13/24
  • IV Low 42.16% on 06/09/23
  • Put/Call Vol Ratio 2.60
  • Today's Volume 695
  • Volume Avg (30-Day) 1,021
  • Put/Call OI Ratio 0.62
  • Today's Open Interest 44,667
  • Open Int (30-Day) 44,307

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.19
  • Number of Estimates 6
  • High Estimate -0.14
  • Low Estimate -0.32
  • Prior Year -0.24
  • Growth Rate Est. (year over year) +20.83%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.03 +32.51%
on 04/25/24
5.70 -6.32%
on 05/07/24
+0.54 (+11.25%)
since 04/09/24
3-Month
4.03 +32.51%
on 04/25/24
6.35 -15.91%
on 02/12/24
-0.51 (-8.72%)
since 02/09/24
52-Week
4.03 +32.51%
on 04/25/24
8.96 -40.40%
on 06/08/23
-3.24 (-37.76%)
since 05/09/23

Most Recent Stories

More News
Why BioCryst Pharmaceuticals Vaulted Nearly 20% Higher on Monday

A better-than-expected first quarter and a goal of profitability and positive cash flow by the end of 2025 brought on a bit of a rally.

BCRX : 5.34 (+4.71%)
BioCryst Pharmaceuticals, Freshpet rise; Luminar, Integra fall, Monday, 5/6/2024

Stocks that traded heavily or had substantial price changes on Monday: BioCryst Pharmaceuticals, Freshpet rise; Luminar, Integra fall

THS : 35.35 (+1.58%)
IART : 25.30 (+1.57%)
FRPT : 118.90 (-0.26%)
BCRX : 5.34 (+4.71%)
NSSC : 44.63 (+0.40%)
BioCryst Pharmaceuticals (BCRX) Q1 2024 Earnings Call Transcript

BCRX earnings call for the period ending March 31, 2024.

BCRX : 5.34 (+4.71%)
BioCryst: Q1 Earnings Snapshot

BioCryst: Q1 Earnings Snapshot

BCRX : 5.34 (+4.71%)
BioCryst Pharmaceuticals (BCRX) Q4 2023 Earnings Call Transcript

BCRX earnings call for the period ending December 31, 2023.

BCRX : 5.34 (+4.71%)
BioCryst: Q4 Earnings Snapshot

BioCryst: Q4 Earnings Snapshot

BCRX : 5.34 (+4.71%)
BioCryst Pharmaceuticals (BCRX) Q3 2023 Earnings Call Transcript

BCRX earnings call for the period ending September 30, 2023.

BCRX : 5.34 (+4.71%)
BioCryst: Q3 Earnings Snapshot

BioCryst: Q3 Earnings Snapshot

BCRX : 5.34 (+4.71%)
3 Magnificent Growth Stocks to Buy on the Dip

These three biotech stocks are attractive buys right now.

AGEN : 11.72 (+2.18%)
BCRX : 5.34 (+4.71%)
NNOX : 10.08 (+6.11%)
BioCryst Pharmaceuticals (BCRX) Q2 2023 Earnings Call Transcript

BCRX earnings call for the period ending June 30, 2023.

BCRX : 5.34 (+4.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

BioCryst Pharmaceuticals, Inc. is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer, cardiovascular diseases, autoimmune diseases, and viral infections. The company is advancing multiple internal programs toward potential...

See More

Key Turning Points

3rd Resistance Point 5.73
2nd Resistance Point 5.54
1st Resistance Point 5.44
Last Price 5.34
1st Support Level 5.15
2nd Support Level 4.96
3rd Support Level 4.86

See More

52-Week High 8.96
Fibonacci 61.8% 7.08
Fibonacci 50% 6.49
Fibonacci 38.2% 5.91
Last Price 5.34
52-Week Low 4.03

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar